Amy Gilbert, Ph.D. is a Director in the cell therapy research organization at Kite Pharma, A Gilead company. Amy received her B.A. in biology from Middlebury College and completed her Ph.D. in Immunology at the National Institute for Health Research Biomedical Research Centre at King’s College London. There she studied novel therapeutic approaches to activate innate and adaptive immune responses in melanoma. Prior to joining Kite Pharma, Amy hold 10+ years of experience in the biotechnology field working at Genentech, Amgen and more recently at Cell Design Labs. At Kite Pharma she leads a team focused on the development and translation of new cell engineering approaches for the treatment of solid tumors.